Life Sciences

Hatteras Venture Partners, one of the Triangle’s most important biotechnology investors, has raised more $137 million for its newest fund,…

DURHAM — As you walk through the imposing glass front entrance at Merck’s Maurice R. Hilleman Center for Vaccine Manufacturing…

RESEARCH TRIANGLE PARK — Life sciences companies in North Carolina that have received federal grants for research and development have…

DURHAM — Polarean, a Duke University spinout, is another step closer to commercializing its proprietary technology for lung imaging. This…

DURHAM — Biotech startup InSoma Bio has raised an additional $200,000 in security, according to a filing with the US…

RESEARCH TRIANGLE PARK — Just a mile down the road from the North Carolina Biotechnology Center, Shattuck Labs is changing…

North Carolina Region’s Life Sciences Research May Help Edge Out Texas Capital. Raleigh-Durham in North Carolina overtook greater Austin, Texas,…

DURHAM —  Emergo Therapeutics, a biopharmaceutical startup founded by serial entrepreneur Moise Khayrallah, has raised roughly $3.5 million in equity, …

RESEARCH TRIANGLE PARK — Grifols, a global biotherapeutics company, has begun Phase 3 clinical trials in patients with COVID-19 with…